Back to search

Article

Molecular mechanisms of Thalidomide effectiveness on COVID-19 patients explained: ACE2 is a new ΔNp63α target gene

2024-04-08

Abstract excerpt

<title>Abstract</title> <p>COVID-19 pandemics is caused by the SARS-CoV-2 virus, whose internalization and infection are mediated by the Angiotensin Converting Enzyme 2 (ACE2). The identification of novel approaches to tackle this step is instrumental for the development of therapies for the management of COVID-19 and other diseases with a similar mechanism of infection. Thalidomide, a drug sadly known for its te...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dfbaa2f3-792d-5871-8e1e-75e934ee256f
DOI
10.21203/rs.3.rs-4162662/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular mechanisms of Thalidomide effectiveness on COVID-19 patients explained: ACE2 is a new ΔNp63α target geneDOI 10.21203/rs.3.rs-4162662/v1
Select a neighboring publication to make it the new centre.